USFDA issues Form-483 with 5 observations to Ajanta Pharma's Paithan facilityAjanta Pharma said the US FDA has issued Form-483 with five observations after inspecting its Paithan manufacturing facility in Maharashtra...
Regulator moves to check import of fake cosmeticsThe Drugs Controller General of India (DCGI) has asked importers of cosmetics to provide information on consignments, bills, quantity impor...
'Most small drug companies unnerved by GMP compliance norm'Union health minister Mansukh Mandaviya had announced last month that companies with a turnover of ₹250 crore and more will have to impleme...
Sun Pharma, other drug cos say innovative products to contribute substantially in futureSun Pharma, India's largest drug maker, said it expects its innovative products to garner $1.5 billion in sales in the next 3-4 years.
Aurobindo Pharma, MSN Labs seek DGCI nod for Phase-III trials of Merck's molnupiravirIn a meeting held on October 4, both the companies said that they “they want to discontinue phase III trial in moderate Covid-19 patients a...
Cipla to tap foreign cos for large-scale vax playMoving beyond a wide portfolio of Covid drugs and diagnostic kits, the Mumbai-based company — with revenues of nearly Rs 20,000 crore — now...
Subramanian Swamy takes on Arvind Subramanian again, terms his continuance 'tolerance'Swamy had in late June trained his guns on Subramanian and demanded his sacking for allegedly taking anti-India stance when he was an IMF e...
Competition, delay in drug approvals may take a toll on pharma cos' healthWith global macro-economic scenario turning volatile, Indian players may have to strategise harder to stay ahead.
- How much will the new drug price regime cost pharma cos
After a span of 18 years, last week India fundamentally altered the way it regulates prices of essential drugs by shifting to a market-base...
Pharma companies adopt tough ethical normsAfter facing flak for illegal drug trials, and unethical marketing practices, the pharma industry seems to be pulling up its socks.
- Elder Pharma set to enter regulated markets of European Union
Diosmin, a semi-synthetic drug, is an oral phlebotropic drug used in the treatment of venous system related diseases. Disease (HD), Microci...
- Elder Pharmaceuticals gets suitability certificate from EDQM for Diosmin
Drug firm Elder Pharmaceuticals today said it has received certificate of suitability for 'Diosmin API', a drug used for the treatment of d...
- Pharmaceutical companies told to submit safety reports on new drugs every 6 months
Companies which failed to report their safety status should do so within 3 weeks to retain their drug licences, the DGCI said.
- Pharmaceutical Export Promotion Council of India seeks clarity from US on new generic drug fee norms
Pharmexcil has sought clarity from the United States Food and Drug Administration (USFDA ) on the new generic drug user fee norms.
- Japan may open up to Indian generics
Japan has veered round to considering India’s demand to open up its over $100-billion pharmaceutical market to Indian generic, or off-paten...
- WIPO clarifies
This is with reference to the story “Global model to give instant patent relief to drug cos” ( ET, May 6), which purports to relate to matt...
- 650 drug companies threaten to stop production
Drug price regulator National Pharmaceutical Pricing Authority had reduced the prices of 33 bulk drugs by up to 10% in March. Night club dr...